Evolved By Nature
Latest round
- Series C
Last raised
- Jun 2022
Total raised
- $120M
Investors
- 6
About Evolved By Nature
, operates as a green chemistry company that provides Activated Silk™ that treats the human eye and rare skin conditions. The company offers chemicals used for leather types, textiles, garments and accessories, natural ingredients, and biomolecules. The company provides various beauty products that include activated Silk™ 33B polypeptide solution used for the protection of cancer-causing harmful UV rays, pollution, and acne-causing irritants.
Who invested in Evolved By Nature
6 investors across 1 round
See all investors in Evolved By Nature
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jun 30, 2022
Amount
$120M
Investors
Questions about Evolved By Nature
Who invested in Evolved By Nature?
Evolved By Nature has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evolved By Nature raised?
Evolved By Nature has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evolved By Nature last raise money?
Evolved By Nature's most recent round on record is a Series C, in Jun 2022.
What does Evolved By Nature do?
, operates as a green chemistry company that provides Activated Silk™ that treats the human eye and rare skin conditions.
Where is Evolved By Nature headquartered?
Evolved By Nature is headquartered in Medford, US.
Which VCs invest in companies like Evolved By Nature?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Evolved By Nature's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Evolved By Nature? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.